BackEditas Medicine Overview
Editas Medicine Inc

Editas Medicine Target Price

See Editas Medicine's analyst price targets ($5.5) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$2.17

Average Target Price

$5.50153.5% upside

2 analysts in the last 4 months

High: $6 | Low: $5

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-10-08Wells Fargo$6176.5% upsideOpen
2026-09-23GuggenheimDebjit Chattopadhyay$5130.4% upsideOpen
2026-05-05Chardan Capital$484.3% upsideOpen
2026-03-09Robert W. Baird$6176.5% upsideOpen
2024-11-05BarclaysGena Wang$5130.4% upsideOpen
2024-10-23Wells FargoYanan Zhu$9314.7% upsideOpen
2024-10-22Robert W. BairdJoel Beatty$10360.8% upsideOpen
2024-08-08Truist FinancialJoon Lee$12453% upsideOpen
2024-08-08Bank of America SecuritiesGreg Harrison$15591.2% upsideOpen
2024-05-30Evercore ISILiisa Bayko$7222.6% upsideOpen
2024-05-09Morgan StanleyMatthew Harrison$7222.6% upsideOpen
2023-09-28Stifel NicolausDae Gon Ha$17683.4% upsideOpen
2022-12-13Citigroup$11406.9% upsideOpen
2022-11-18Morgan Stanley$8268.7% upsideOpen
2022-11-18RBC Capital$14545.2% upsideOpen
2022-11-18Truist FinancialJoon Lee$351512.9% upsideOpen
2022-11-18Oppenheimer$12453% upsideOpen
2022-11-18Credit Suisse$13499.1% upsideOpen
2022-11-18Chardan Capital$351512.9% upsideOpen
2022-01-06Morgan StanleyMatthew Harrison$241006% upsideOpen
2021-11-08Robert W. BairdJoel Beatty$441927.6% upsideOpen
2021-09-29Truist FinancialJoon Lee$803586.6% upsideOpen

Editas Medicine (EDIT) FAQ

Editas Medicine (EDIT) currently reports a target price of $5.5. Use the charts on this page to explore Editas Medicine's target price history and peer comparisons.

Analysts' average 12-month price target for Editas Medicine is $5.5, about 153.5% upside from the current share price of $2.17. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $5.5, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Editas Medicine, and consider following EDIT for alerts when major investors trade the stock.

Editas Medicine is classified in the Healthcare sector. On target price, it currently shows $5.5. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EDIT with unrelated industries.